Bayer HealthCare Pharma
Bayer HealthCare Pharma is comprised of Specialty Medicine (consisting of Haematology, Neurology, Oncology and Ophthalmology) and General Medicine (including Women’s Health)
Following the acquisition of Schering Healthcare in 2006, the largest purchase in Bayer’s history, Bayer HealthCare Pharma became one of the world’s leading pharmaceutical specialists. It aims to discover and manufacture innovative products that will improve patients’ lives. Bayer’s products enhance well-being and quality of life by diagnosing, preventing and treating a number of different conditions.